A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes

Clinical trial NCT03952130 · COMPLETED

Trial details

NCT number: NCT03952130
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2019-05-29
Primary completion: 2022-01-10
Enrollment: 354

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.